The novel approach of this peptide represents a exciting advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – https://tirzepatidepeptide982503.blogaritma.com/39840979/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment